Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Bright Minds Biosciences Inc C.DRUG

Alternate Symbol(s):  DRUG

Healthcare Biotechnology
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical... see more

Current News (CSE:DRUG)

Bright Minds Biosciences to Present at Upcoming Conferences

GlobeNewswire February 25, 2026

Canadian Securities Exchange Reports January 2026 Performance Figures

Newsfile February 17, 2026

Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

GlobeNewswire January 9, 2026

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

GlobeNewswire January 7, 2026

Bright Minds Biosciences Announces Launch of US$100 Million Public Offering

GlobeNewswire January 6, 2026

Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)

GlobeNewswire January 6, 2026

Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026

GlobeNewswire January 5, 2026

Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting

GlobeNewswire November 25, 2025

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

GlobeNewswire November 17, 2025
View More News ››

Opinion & Analysis (CSE:DRUG)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:DRUG)

HEAVY NEWS --- GOV'T OF CANADA INVOLVEMENT 🇨🇦

"After 34 years in federal policing, I've seen what happens when frontline teams don't have timely, reliable intelligence on...
GajjarDr - 10 days ago

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - January 6, 2026

RE:Just a heads up

Fda approved for 40 pennies a share.Wow what a deal.This will soon fly once the contracts start pouring in.What an opportunity to load up...
Larder111 - August 22, 2025

Just a heads up

Phrm, pharmather is poised to become the next Drug.  Just received FDA approval, low share count. CEO holding over 16 Million shares...
Tommyjohn - August 16, 2025

Time to start buying again

Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101: https://stockhouse.com/news...
johnnydang - May 13, 2025

looks like our partner Firefly is at it again.....

https://www.newsfilecorp.com/release/243458
loaddumper - March 6, 2025
View more Bullboard ››

Allied Critical Metals Inc.

Allied Critical Metals Inc.

Allied Critical Metals (ACM:CSE) is a Canadian-based mining company focused on the expansion and revitalization of its 100 ...
View More »

Podcasts